Looking ahead to 2022

It is a huge privilege to lead the largest professional membership body working in sexual and reproductive healthcare in the UK.

FSRH Asha KasliwalAs we reflect on 2021, we have much to be proud of, as an organisation and of the members we represent. We could not do the work we do without your support, guidance and expertise.  

2021 saw both milestones and progressions in the sphere of sexual and reproductive health.  

We celebrated the contraceptive pill turning 60 this year, an invention that revolutionised the lives of women and set society on a course of liberating women’s sexual and reproductive health. Fast-forward to 2021, we supported the proposal to make it easier for women to obtain the progestogen-only contraceptive pill in pharmacies without the need for a prescription. A first for women in the UK, this act meant that it is now easier for women to access essential contraception to avoid unplanned pregnancies during and beyond COVID-19.  

Our continued Telemedicine Facts campaign highlighted the need to focus on safety, ease of access and safeguarding of young people – as well as addressing myths in relation to abortion care. 

We are proud to be at the helm of change when it comes to increasing access to contraception and the safety of all women.   

However, with the ever-changing medical landscape and new variants of COVID-19 threatening service provision, we recognise that the need for non-judgmental, safe and effective sexual and reproductive health is as important as ever. We will be continuing the work we do in 2022 and beyond.  

Following on from the success of 2021, we are already planning our next set of Hot Topic events and our renowned online conference FSRH Virtual 2022, delivering the latest guidance and updates from the world of sexual and reproductive health.  

We are continuing to develop a range of learning resources to support healthcare professionals in our online Training Hub. 2022 is also the Year of the Trainer, where we will be sharing a range of resources, content and communications to support our Faculty Registered Trainers and General Training Programme Directors. 

We are planning to share upcoming guidance on topics including the Progestogen-only Pill; Breast Cancer After Contraception; and Intrauterine Contraception. 

Finally, I would like to thank our members, staff and all those who have given their time on FSRH committees, Council and as trainers. It is your expertise, support and knowledge that makes us increasingly effective and influential. 

I hope we can count on your continued support in 2022 and beyond. 

Dr Asha Kasliwal
FSRH President